Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Clarke

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Molecular Oncology|December 1, 2021
FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomasChristopher I Milton, Joanna Selfe, Ewa Aladowicz, et al.
Cancer Research|March 17, 2019
MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic TreatmentKonstantinos Zormpas-Petridis, Neil P Jerome, Matthew D Blackledge, et al.
Nature|July 6, 2018
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesionsMichal Zimmermann, Olga Murina, Martin A M Reijns, et al.
The Lancet. Child & Adolescent Health|March 20, 2019
Identification of new Wilms tumour predisposition genes: an exome sequencing studyShazia Mahamdallie, Shawn Yost, Emma Poyastro-Pearson, et al.
Communications Biology|May 18, 2019
ALK2 inhibitors display beneficial effects in preclinical models of <i>ACVR1</i> mutant diffuse intrinsic pontine gliomaDiana Carvalho, Kathryn R Taylor, Nagore Gene Olaciregui, et al.
Lancet (London, England)|March 24, 2026
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trialDavid J Thomson, James M Price, Matthew Tyler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2022
Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centresLone Hoffmann, Hanna Mortensen, Muhammad Shamshad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone SensitivityGunther Boysen, Daniel N Rodrigues, Pasquale Rescigno, et al.
The Journal of Clinical Investigation|December 25, 2019
Genomics of lethal prostate cancer at diagnosis and castration resistanceJoaquin Mateo, George Seed, Claudia Bertan, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Molecular Oncology|December 1, 2021
FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomasChristopher I Milton, Joanna Selfe, Ewa Aladowicz, et al.
Cancer Research|March 17, 2019
MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic TreatmentKonstantinos Zormpas-Petridis, Neil P Jerome, Matthew D Blackledge, et al.
Nature|July 6, 2018
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesionsMichal Zimmermann, Olga Murina, Martin A M Reijns, et al.
The Lancet. Child & Adolescent Health|March 20, 2019
Identification of new Wilms tumour predisposition genes: an exome sequencing studyShazia Mahamdallie, Shawn Yost, Emma Poyastro-Pearson, et al.
Communications Biology|May 18, 2019
ALK2 inhibitors display beneficial effects in preclinical models of <i>ACVR1</i> mutant diffuse intrinsic pontine gliomaDiana Carvalho, Kathryn R Taylor, Nagore Gene Olaciregui, et al.
Lancet (London, England)|March 24, 2026
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trialDavid J Thomson, James M Price, Matthew Tyler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)Jonathan Welti, Adam Sharp, Wei Yuan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2022
Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centresLone Hoffmann, Hanna Mortensen, Muhammad Shamshad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone SensitivityGunther Boysen, Daniel N Rodrigues, Pasquale Rescigno, et al.
The Journal of Clinical Investigation|December 25, 2019
Genomics of lethal prostate cancer at diagnosis and castration resistanceJoaquin Mateo, George Seed, Claudia Bertan, et al.
Pageof 7